by on August 12, 2025
Introduction Modafinil, a wakefulness-selling agent, has garnered important consideration since its approval by the FDA in 1998 for the therapy of narcolepsy, sleep apnea, and shift work sleep disorder. Its off-label use as a cognitive enhancer has led to a burgeoning interest in its effects amongst healthy individuals, significantly college students and professionals looking for to improve focus, productiveness, and cognitive efficiency. This text presents an observational evaluation of modafi...
6 views 0 likes